Skip to main content

Published locations for Canagliflozin lowers kidney failure risk in T2D: CREDENCE

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Canagliflozin lowers kidney failure risk in T2D: CREDENCE

User login

  • Reset your password
  • /content/canagliflozin-lowers-kidney-failure-risk-t2d-credence
  • /clinicianreviews/article/198850/diabetes/canagliflozin-lowers-kidney-failure-risk-t2d-credence
  • /familypracticenews/article/198850/diabetes/canagliflozin-lowers-kidney-failure-risk-t2d-credence
  • /fedprac/article/198850/diabetes/canagliflozin-lowers-kidney-failure-risk-t2d-credence
  • /internalmedicinenews/article/198850/diabetes/canagliflozin-lowers-kidney-failure-risk-t2d-credence
  • /clinicalendocrinologynews/article/198850/diabetes/canagliflozin-lowers-kidney-failure-risk-t2d
  • /ecardiologynews/article/198850/diabetes/canagliflozin-lowers-kidney-failure-risk-t2d-credence
  • /cardiology/article/198850/diabetes/canagliflozin-lowers-kidney-failure-risk-t2d-credence
  • /endocrinology/article/198850/diabetes/canagliflozin-lowers-kidney-failure-risk-t2d-credence
  • /internalmedicine/article/198850/diabetes/canagliflozin-lowers-kidney-failure-risk-t2d-credence
  • /familymedicine/article/198850/diabetes/canagliflozin-lowers-kidney-failure-risk-t2d-credence
  • /type-2-diabetes-icymi/article/198850/diabetes/canagliflozin-lowers-kidney-failure-risk-t2d-credence